TREE NEWS reports: Injective CEO Eric Chen said he expects a US ETF tied to INJ to launch before 2027, calling the year “a bit too far” out. Speaking to The Block during Korea Blockchain Week, Chen declined to comment on a specific timeline. 21Shares and Canary have already filed INJ ETF applications with the SEC.
Injective CEO Eric Chen Expects US INJ-Linked ETF by 2027
AI take
A CEO's expectation is not a regulatory signal, and Chen's own refusal to give a timeline is the more telling detail. What matters is that two issuers have already filed, so the INJ ETF question now sits with the SEC rather than with Injective's leadership. For token holders, the filing pipeline is the substantive development; the executive forecast is commentary on top of it. Whether those applications advance, stall, or join the broader queue of altcoin ETF requests is the open question worth tracking.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
2h ago
Bitcoin Slips Below $86,000, Still Up 0.86% on the Day
2h ago
Kelsier Ventures-Linked Addresses’ Assets Fell From Nearly $300M to $2M
2h ago
Bloomberg Terminal Adds Hyperliquid Perp Price Feeds, No Trading
2h ago
Most LIBRA Claims Dismissed in New York Over Jurisdiction
3h ago
CZ Says He Owns Just Three Cars: One Nissan SUV and Two Minivans
4h ago
The Rollup Founder Andy Hints Polymarket Token POLY Is Coming